ALVAC-CEA vaccine

ALVAC-CEA vaccine

ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.

A phase I trial in 118 patients showed safety in humans.[1]

References

External links

  • ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates "Dictionary of Cancer Terms".